Adalimumab (Humira) – Autoimmune Disease Treatment

What is Adalimumab?

Adalimumab, commonly known as Humira, is a monoclonal antibody that blocks tumor necrosis factor (TNF), a protein that causes inflammation in autoimmune diseases. It is used for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and psoriasis.

Benefits of Adalimumab (Humira)

• Reduces inflammation: Helps manage pain and swelling in autoimmune disorders.
• Treats multiple conditions: Effective for arthritis, psoriasis, and bowel diseases.
• Prevents disease progression: Slows joint damage in arthritis patients.
• Long-term management: Used for chronic autoimmune conditions.

Humira is injected subcutaneously and requires regular monitoring by a healthcare provider.